Dr Anja König joins the Board of F2G representing Novartis Venture Funds where she is a Managing Director based in Basel. Anja represents NVF across Europe and is also active on the US East Coast. She holds a PhD is Physics from Cornell University and a physics degree from the University of Munich. Anja holds a number of Board positions for NVF portfolio companies including Bicycle, Covagen, F2G, Heptares, and Nabriva. Prior to joining NVF Anja was Associate Partner at McKinsey and Company a global consultancy, where she worked with companies in health care in the US, Europe and Emerging Markets.